skip to Main Content
UK CBD Regulators Under Fire After Last Minute Change To Novel Food Rules
UK CBD regulator the Food Standards Agency (FSA) has changed its approach to Novel Food compliance – just weeks before its deadline as it struggles to cope with the number of applications.

In February last year the FSA told the CBD industry that to stay on the UK market they needed to have their applications for Novel Food products Validated by March 31, 2020.

An FSA statement published yesterday highlighted how it had changed this position and would now accept applications until March 31.

It also ‘shifted the goalposts’ by saying it will allow applications it would have previously regarded as sub-standard to remain on the market until these applications have set out ‘robust plans to provide any necessary information’.

FSA ‘Struggling To Cope’

Many in the industry have been left aghast at the change in position after spending hundreds of thousands of pounds aligning with the FSA’s initial guidance.

However, there will be some in the industry who will welcome this move as it allows them time to align with the requirements, but for many diligent market participants, closely aligned to the FSA’s previous guidance, it is being taken as a low blow.

It appears that the FSA is struggling to cope with the number and quality of applications, despite significantly boosting the number of staff assigned to the task.

BusinessCann recently reported that 138 – over one-third – of the 404 applications it had received by the end of February ‘have been assessed and not passed the Admin check’.

The FSA still had a further 227 to consider and with more applications pouring in every day it appears to be struggling to cope.

Yesterday’s change of stance was announced as following: “The FSA will also publish a list of products associated with applications which have not yet fully met the legal requirements to be validated but have set out sufficiently robust plans to prove they are fully committed to delivering the remaining information required.

“This will include evidence of plans to complete the risk assessment process, with a clear deadline for submission of the outstanding information.”

Moving The Goalposts

Steve Oliver, of The Canna Consultants, which has submitted applications on behalf of almost a dozen of its clients said: “With today’s announcement we would suggest that the FSA have significantly moved the goalposts after the start of the match.

“The question is why they didn’t listen to the industry and begin with the ‘submitted by March 31’ suggestion we made to them 12 months ago.

“ They have now placed themselves under under-pressure, post-Brexit with the ‘validated by March 31’  only to then change it and create a further category of application to cover their failings with only weeks to go.  Are the FSA ‘making it up as they go along’?

Greer Deal, a Director at Global Regulatory Services, told BusinessCann: “Food Standards Agency this is not fair on the CBD Industry and those of us who have ‘busted a gut’ to support companies in order to submit their applications in time for validation by March 31, 2021.

“I have always supported regulators because I know they have a tough job to do but, in this instance, it’s difficult to remain supportive when confusion and moving of the goalposts is caused by the regulator themselves.”

In a statement to BusinessCann the FSA said: “We will publish a list of products associated with applications which have not yet fully met the legal requirements to be validated but have set out sufficiently robust plans to prove they are fully committed to delivering the remaining information required.

“This will include evidence of work underway to gather the outstanding information, which is considered to be of good quality, and a clear and proportionate deadline for submission of the evidence.

“Failure to submit the remaining evidence in a timely fashion will result in the relevant products being removed from any published list.”

Three Stages To The Novel Food Process

The first is the Administrative check, to ensure all the required documentation is in place, the second is Validation; ensuring it matches the requirements, including details on safety and toxicology and finally Authorisation.

The Authorisation process can take a further year and once complete allows products to be sold in the UK.

Peter McCuskerPeter McCusker

Peter McCusker

Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].

BusinessCann is an online news publication, which supports the growth of Europe’s Hemp, CBD and Medicinal Cannabis industries by providing factual and feature articles, comment and profiles on the people and businesses forging its growth and development.
This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

Public health and safety organizations engage workgroup to develop regulatory framework for cannabis in the U.S.

PRESS RELEASE June 28, 2022 –  The Association of Food and Drug Officials (AFDO) and Foundation of Cannabis United Standards (FOCUS) have officially launched efforts to develop a Federal Regulatory Framework, or FRF, for cannabis in the U.S. “Federal involvement and regulatory oversight of the U.S. cannabis industry is imperative to the health and safety…

Alcohol Regulation as a Model for Cannabis Regulation: the Benefits and Drawbacks

By John West, Agustin Rodriguez, Nicholas Ramos, Christina Sava, Chelsey Noble The rapid evolution of the cannabis industry in the United States poses many unique questions, the most interesting of which is what cannabis regulation will look like under federal legalization. Although (legal) cannabis is a brand new industry, it is not the first time…

First Amendment May Help Cannabis Companies Beat Trademark Infringement Claims

By Fred Rocafort, Attorney at Harris Bricken The U.S. Constitution’s free speech protections, found in the First Amendment, may present a legal recourse for cannabis brands in trouble for using marks that are similar to famous trademarks. To be clear, a free speech argument will not be of help to those who simply copy a…

NC Medical Marijuana Bill Held Up As Industrial Hemp Laws Sunset

There’s a growing industry here in North Carolina, and with it come countless rules, gray areas, and legal confusion—and no, we’re not talking about NFTs. The hemp industry has been blooming in the state for years, but North Carolina is one of 12 states that doesn’t have a medical marijuana program. With the end of the…

More Categories

Back To Top
×Close search